Vimta Labs Share Price

NSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vimta Labs
Vimta Labs Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Vimta Labs Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
133.95% Gain from 52W Low
19.1
Dividend yield 1yr %
Low in industry
0.2

Vimta Labs Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
89.92 Cr
84.74 Cr
81.76 Cr
79.69 Cr
81.68 Cr

Vimta Labs Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
322.27 Cr
321.63 Cr
279.73 Cr
211.51 Cr
183.73 Cr

Vimta Labs Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
17.52 Cr
17.02 Cr
12.28 Cr
12.35 Cr
10.13 Cr

Vimta Labs Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
41.01 Cr
48.17 Cr
41.33 Cr
21.4 Cr
6.84 Cr
Vimta Labs Result Highlights
  • Vimta Labs Ltd reported a 6.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.4%.

  • Its expenses for the quarter were up by 5.8% QoQ and down 2.7% YoY.

  • The net profit increased 41.0% QoQ and increased 112.2% YoY.

  • The earnings per share (EPS) of Vimta Labs Ltd stood at 9.6 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Vimta Labs shareholding Pattern

Promoter
36.8%
Foreign Institutions
3.8%
Mutual Funds
0.1%
Domestic Institutions
1.2%
Public
58.3%
Promoter
36.9%
Foreign Institutions
3.3%
Public
59.8%
Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.4%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%
Promoter
37%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.8%

Vimta Labs Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
957.30
10Day EMA
960.40
12Day EMA
964.50
20Day EMA
975.10
26Day EMA
977.50
50Day EMA
967.00
100Day EMA
911.00
200Day EMA
802.40
5Day SMA
929.30
10Day SMA
950.30
20Day SMA
1,008.30
30Day SMA
986.40
50Day SMA
979.80
100Day SMA
949.10
150Day SMA
830.20
200Day SMA
756.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
41132 Rs
104082 Rs
Week Rs
47131 Rs
156138 Rs
Month Rs
58595 Rs
174958 Rs
Resistance & Support
993.70
Pivot
Resistance
First Resistance
1,011.30
Second Resistance
1,040
Third Resistance
1,057.60
Support
First Support
965
Second support
947.40
Third Support
918.70
Relative Strength Index
50.40
Money Flow Index
47.81
MACD
-13.04
MACD Signal
-5.86
Average True Range
79.65
Average Directional Index
16.31
Rate of Change (21)
-5.94
Rate of Change (125)
77.03

Vimta Labs Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202324, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
Read More

Vimta Labs FAQs

Vimta Labs share price is ₹982.6 in NSE and ₹982 in BSE as on 15/4/2025.

Vimta Labs share price in the past 1-year return was 113.51. The Vimta Labs share hit a 1-year low of Rs. 420 and a 1-year high of Rs. 1178.

The market cap of Vimta Labs is Rs. 2184.76 Cr. as of 15/4/2025.

The PE ratios of Vimta Labs is 37.35 as of 15/4/2025.

The PB ratios of Vimta Labs is 6.45 as of 15/4/2025

The Mutual Fund Shareholding in Vimta Labs was 0.13% at the end of 15/4/2025.

You can easily buy Vimta Labs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Vimta Labs stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -